SecBot SecBot
144 ·Filed May 28, 2026

ANAB

ANAPTYSBIO, INC
NEUTRAL
Impact 3/10
Horizondays Processed5mo ago SEC0001950047-26-005251
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

The officer's consistent selling over two weeks is notable but not alarming given the modest size relative to market cap (~0.035% of shares outstanding). Monitor for any acceleration of insider sales or a Form 4 filing confirming execution. No immediate trading catalyst.

DirectionNeutral
Confidencemedium
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$55.67
T+0 close · May 28, 2026 · via day close
Latest settled
+4.98%
T+60 · $58.44
Vs SPY
+3.79%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 29 $55.67entry
  2. T+1 · 6mo ago −4.54%α −4.80% · $53.14
  3. T+5 · 6mo ago −9.52%α −7.00% · $50.37
  4. T+20 · 5mo ago +18.50%α +20.30% · $65.97
  5. T+60 · 3mo ago +4.98%α +3.79% · $58.44

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Dennis Mulroy, an officer of AnaptysBio, filed a Form 144 on May 28, 2026, indicating intent to sell 10,264 shares of common stock valued at approximately $594,671. The proposed sale follows a series of recent open-market sales totaling 75,467 shares for about $4.3 million between May 15 and May 27, 2026, and is tied to a stock option exercise. While the filing signals insider intent to monetize equity, the officer has been a consistent seller over the past two weeks, which may raise mild concern but is not unusual for routine option exercises and diversification.

Key Facts

  • Officer Dennis Mulroy filed Form 144 on May 28, 2026, to sell 10,264 shares of common stock.
  • The proposed sale has an approximate market value of $594,671 based on a $57.93 per share price.
  • The shares to be sold are from a stock option exercise executed on May 28, 2026.
  • Mulroy has sold 75,467 shares in seven separate transactions between May 15 and May 27, 2026, totaling approximately $4.3 million.
  • The filing is an advance notice of intent to sell; the actual sale may not occur.
  • AnaptysBio has a market cap of $1.7 billion and analyst consensus is 89% bullish (16 Buy, 2 Hold).

Financial Impact

Proposed sale of 10,264 shares valued at ~$594,671; cumulative recent sales of 75,467 shares for ~$4.3 million.

dilution

Risk Factors

  • Insider selling may signal lack of confidence if it accelerates or becomes material relative to holdings.
  • Form 144 is only an intent to sell; the sale may not be executed.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (18 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-005251
Document: 0001950047-26-005251-index.html0001950047-26-005251
Document: 0001950047-26-005251.txt0001950047-26-005251

Track record

28 reports on ANAB

Performance horizon

10 of 19 bullish or bearish reports moved the stock their way by T+1. Best: +41.26% at T+60 after the Mar 3, 2026 report. 13 of 19 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $46.25 Now $45.73 −1.12% settles Nov 17
  2. Nov 12, 20264d ago Press Release Bearish 4/10 Entry $46.25 to $45.73 Now $45.73 +1.12% ▲ +1.12% −0.79% vs SPY
  3. Nov 6, 202610d ago Institutional Cluster Neutral 2/10 Entry $46.45 to $47.97 Now $45.73 −1.55% ▲ +3.27% +0.91% vs SPY
  4. Sep 21, 20268w ago Press Release Neutral 5/10 Entry $53.92 to $50.77 Now $45.73 −15.19% ▼ −5.84% −5.12% vs SPY
  5. Aug 12, 202613w ago Institutional Cluster Bullish 5/10 Entry $56.02 to $58.47 Now $45.73 −18.37% ▲ +4.37% +4.57% vs SPY
  6. Jun 29, 202620w ago 144 Bearish 6/10 Entry $67.50 to $65.43 Now $45.73 +32.25% ▲ +3.07% +2.93% vs SPY
  7. Jun 29, 202620w ago DEFA14A Neutral 2/10 Entry $67.50 to $65.43 Now $45.73 −32.25% ▼ −3.07% −2.93% vs SPY
  8. Jun 26, 202620w ago 144 Bearish 6/10 Entry $65.97 to $67.50 Now $45.73 +30.68% ▼ −2.32% −1.54% vs SPY
  9. Jun 22, 202621w ago 8-K Neutral 2/10 Entry $59.43 to $58.48 Now $45.73 −23.05% ▼ −1.60% −1.55% vs SPY
  10. Jun 17, 202621w ago 144 Bearish 5/10 Entry $57.51 to $59.99 Now $45.73 +20.48% ▼ −4.31% −4.63% vs SPY
Showing 10 of 28

US Market Status

Market Closed · Opens in 6h 34m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 28, 2026